MONTE ROSA THERAPEUTICS INC (GLUE) Institutional Ownership Changes & 13F Activity
MONTE ROSA THERAPEUTICS INC (GLUE). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Price T Rowe Associates Inc, Vestal Point Capital, Lp, Woodline Partners Lp, Braidwell Lp, and Opaleye Management Inc..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | Sell | -17,924 | -8.5% | 191,877 | $4.64M | Q2 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -90,947 | -35.7% | 163,571 | $3.96M | Q2 2026 | Sep 02, 2026 |
| Corient Private Wealth Llc | Buy | +214 | +1.1% | 19,120 | $462.70K | Q2 2026 | Aug 27, 2026 |
| California State Teachers Retirement System | Buy | +50,907 | +1547.8% | 54,196 | $1.31M | Q2 2026 | Aug 24, 2026 |
| Mercer Global Advisors Inc | Sell | -1,475 | -12.2% | 10,631 | $257.27K | Q2 2026 | Aug 19, 2026 |
| Empowered Funds, Llc | Buy | +23,868 | +7.8% | 329,266 | $7.97M | Q2 2026 | Aug 17, 2026 |
| Seven Fleet Capital Management Lp | Sell | -5,730 | -25.4% | 16,800 | $406.56K | Q2 2026 | Aug 17, 2026 |
| Price T Rowe Associates Inc | Buy | +2,140,983 | +31.9% | 8,861,171 | $214.44M | Q2 2026 | Aug 14, 2026 |
| Vestal Point Capital, Lp | Buy | +996,535 | +27.7% | 4,600,000 | $111.32M | Q2 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Buy | +888,388 | +1192.5% | 962,884 | $23.30M | Q2 2026 | Aug 14, 2026 |
| Braidwell Lp | Sell | -755,012 | -23.5% | 2,451,562 | $59.33M | Q2 2026 | Aug 14, 2026 |
| Opaleye Management Inc. | Buy | +745,000 | — | 745,000 | $18.03M | Q2 2026 | Aug 14, 2026 |
| Suvretta Capital Management, Llc | Sell | -677,270 | -16.0% | 3,549,539 | $85.90M | Q2 2026 | Aug 14, 2026 |
| Boone Capital Management Llc | Buy | +615,287 | — | 615,287 | $14.89M | Q2 2026 | Aug 14, 2026 |
| Nextech Invest, Ltd. | Buy | +456,916 | +150.2% | 761,153 | $18.42M | Q2 2026 | Aug 14, 2026 |
| Ameriprise Financial Inc | Buy | +383,335 | — | 383,335 | $9.28M | Q2 2026 | Aug 14, 2026 |
| Kennedy Capital Management Llc | Buy | +373,552 | +1168.2% | 405,529 | $9.81M | Q2 2026 | Aug 14, 2026 |
| Duquesne Family Office Llc | Buy | +297,600 | — | 297,600 | $7.20M | Q2 2026 | Aug 14, 2026 |
| Longaeva Partners L.P. | Buy | +216,792 | — | 216,792 | $5.25M | Q2 2026 | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | Buy | +200,000 | +80.0% | 450,000 | $10.89M | Q2 2026 | Aug 14, 2026 |
| J. Goldman & Co Lp | Sell | -156,652 | -91.2% | 15,119 | $365.88K | Q2 2026 | Aug 14, 2026 |
| Stempoint Capital Lp | Buy | +153,544 | — | 153,544 | $3.72M | Q2 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Sell | -137,835 | -20.9% | 520,648 | $12.60M | Q2 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -132,981 | -34.3% | 254,561 | $6.16M | Q2 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Buy | +121,623 | +630.2% | 140,923 | $3.41M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +121,121 | — | 121,121 | $2.93M | Q2 2026 | Aug 14, 2026 |
| Caption Management, Llc | Buy | +112,322 | — | 112,322 | $2.72M | Q2 2026 | Aug 14, 2026 |
| Jain Global Llc | Buy | +110,647 | — | 110,647 | $2.68M | Q2 2026 | Aug 14, 2026 |
| Diadema Partners Lp | Sell | -108,916 | -58.1% | 78,391 | $1.90M | Q2 2026 | Aug 14, 2026 |
| D. E. Shaw & Co., Inc. | Buy | +105,726 | +159.4% | 172,053 | $4.16M | Q2 2026 | Aug 14, 2026 |
Frequently asked questions about GLUE activity
Which institutional owners are buying GLUE?
Institutional owners buying GLUE include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in GLUE activity?
"Buy" means an investor increased their reported position in GLUE compared to the prior reporting period. This reflects growing exposure to MONTE ROSA THERAPEUTICS INC (GLUE) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in GLUE increasing?
Institutional interest in GLUE can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related GLUE Institutional Insights
- GLUE Overview
- GLUE 13F Institutional Holders
- GLUE Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- GLUE Insider Trading & SEC Form 4 Activity
- GLUE Articles
- Top Institutional Investor Stock Rankings